The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma

por Khoja, Leila, Atenafu, Eshetu G., Templeton, Arnoud, Qye, Ye, Chappell, Mary Anne, Saibil, Sam, Hogg, David, Butler, Marcus O., Joshua, Anthony M.
Publicado 2016